Dance Biopharm Inc.: Clinical Trials

3 completed, 1 terminated. 4 Phase 2, 2 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	4	Completed 3, Terminated 1
Phase 1	2	Completed 2

Follow Dance Biopharm Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Dose Response of Dance 501 in Subjects With Type 2 Diabetes Mellitus Inhaled Human Insulin, Insulin Lispro (Humalog U-100) - Type 2 Diabetes Mellitus	Phase 2	Completed	Dance Biopharm Inc.	24	2018-04-23	2019-09-24
PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD inhaled human insulin, Insulin Lispro (Humalog U-100) - Safety and Tolerability	Phase 2	Terminated	Dance Biopharm Inc.	40	2018-02-06	2019-09-13
Dose-Response and Variability of Inhaled Insulin in Type 2 Diabetes INH 69 U (low), INH 69 U (high), INH 139 U - Type 2 Diabetes Mellitus	Phase 1 / Phase 2	Completed	Dance Biopharm Inc.	24	2013-10-01	2016-03-23
Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes inhaled human insulin (INH), sc insulin lispro (LIS) - Type 1 Diabetes Mellitus	Phase 1 / Phase 2	Completed	Dance Biopharm Inc.	12	2013-05-01	2016-03-21

Conditions studied

Diabetes Mellitus, Type 2 (2)  ·  Asthma (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Interventions

Insulin Lispro (2)  ·  Isoniazid (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Tim Heise, MD (2)  ·  Oliver Klein (1)  ·  Timothy S Bailey, MD (1)